Position in ROIV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$297,063
New position
Shares Held
8,394
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#324
of 494 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026TCW GROUP INC holds $17,275,887 across 10 Biotechnology names. ROIV ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
193,648 | $11,080,537 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,266 | $2,119,050 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,695 | $1,056,900 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,236 | $673,103 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,109 | $582,253 | |
| 6 | MRNA |
Moderna, Inc.
|
5,957 | $417,168 | |
| 7 | INSM |
INSMED Inc
|
3,604 | $384,258 | |
| 8 | RPRX |
Royalty Pharma plc
|
6,193 | $347,241 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297,063 | 8,394 | Shares | Defined | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||